Release Date: 04/02/16 15:50 Summary: Change in substantial holding from AMP Price Sensitive: No Download Document 420.44KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%